Covestro LLC polycarbonates instrumental to orthopedic surgery innovation

Replacing stainless steel instruments with plastic offers a more-convenient option for hospitals and surgical centers

Anaheim, Calif., February 7, 2017 — Orthopedic implants are helpful in restoring the quality of life for patients suffering from pain and reduced mobility. Bio2 Technologies of Woburn, Massachusetts, has developed Vitrium® Bioactive Glass Implants that are an alternative to allograft and porous metals. In addition to this innovative material, the company is also taking a novel approach to the surgical procedure with plans to replace stainless steel instruments used in two implant applications with instruments made of Covestro LLC polycarbonate.

An instrument set used in conjunction with orthopedic implant surgery consists of a number of templates that help the surgeon determine the appropriate implant to achieve the desired correction. Traditionally, stainless steel instruments are used but these instruments are more expensive and must be sterilized before each procedure. Instruments formed from Makrolon® Rx1805 polycarbonate are disposable – a more convenient option for hospitals and surgical centers.

Bio2 Technologies’ Vitrium C and Vitrium E implants have received FDA clearance and are currently available in the U.S. for reconstructive surgery of the extremities. Bio2 Technologies plans to offer disposable polycarbonate instruments following completion of a packaging and sterilization validation study, which is expected mid-year.

According to Art O’Dea, Vice President Operations and Legal Affairs, Bio2 Technologies, Covestro did more than just supply the plastic. “Covestro provided mold flow analysis and made recommendations related to mold construction,” said “O’Dea. “This technical support was very valuable.”

“Covestro is well-known for going the extra mile to support our customers,” said Anthony Leo, field market development, Polycarbonates, Covestro LLC: “In this case, we were able to leverage our substantial materials expertise to help Bio2 Technologies achieve its vision for a disposable instrument kit that would complement its Vitrium C and E Wedges.”

Makrolon® Rx1805 medical-grade polycarbonate is part of Covestro’s broad portfolio of polycarbonate resins. Thanks to its documented biocompatibility, this grade offers good chemical resistance and is often used in medical technology applications that require contact with body fluids.

“For decades, medical OEMs have relied on the proven performance of Makrolon® polycarbonate resin,” said Lauren Zetts, North America market manager, Medical and Consumer Products – Polycarbonates, Covestro LLC. “This application is just the latest example of how medical OEMs can add value by replacing traditional materials with engineering plastics.”

Attendees at MD&M West Conference and Exposition, Feb. 7-9, in Anaheim, California, can visit Covestro’s booth (#2021) for more details about medical applications and materials from Covestro.

About Covestro LLC:

Covestro LLC is one of the leading producers of high-performance polymers in North America and is part of the global Covestro business with 2015 sales of EUR 12.1 billion. Covestro manufactures high-tech polymer materials and develops innovative solutions for products used in many areas of daily life. The main segments served are the automotive, electrical and electronics, construction, medical and sports and leisure industries. The Covestro group has 30 production sites around the globe and employed approximately 15,800 people at the end of 2015.

Find more information at www.covestro.com or www.plastics.covestro.com.

Makrolon® is a registered trademark of the Covestro Group.

Covestro Contact:

John Skabardonis, Phone: +1 412 413 5444
John.Skabardonis@covestro.com

# # #

This press release may contain forward-looking statements based on current assumptions and forecasts made by Covestro AG. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Covestro’s public reports which are available on the Covestro website at www.covestro.com. Covestro assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Editor’s Note: Follow news from Covestro on Twitter:
www.twitter.com/CovestroGroup